T. Rowe Price Associates’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $706K | Buy |
257,427
+68,788
| +36% | +$218K | ﹤0.01% | 2305 |
|
|
2025
Q4 | $698K | Buy |
188,639
+35,749
| +23% | +$116K | ﹤0.01% | 2246 |
|
|
2025
Q3 | $406K | Buy |
152,890
+18,376
| +14% | +$35.5K | ﹤0.01% | 2456 |
|
|
2025
Q2 | $132K | Buy |
134,514
+8,961
| +7% | +$8.97K | ﹤0.01% | 2835 |
|
|
2025
Q1 | $181K | Buy |
125,553
+1,657
| +1% | +$3.05K | ﹤0.01% | 2682 |
|
|
2024
Q4 | $273K | Buy |
123,896
+16,404
| +15% | +$38.3K | ﹤0.01% | 2548 |
|
|
2024
Q3 | $178K | Hold |
107,492
| – | – | ﹤0.01% | 2691 |
|
|
2024
Q2 | $239K | Buy |
107,492
+72,092
| +204% | +$170K | ﹤0.01% | 2522 |
|
|
2024
Q1 | $95K | Hold |
35,400
| – | – | ﹤0.01% | 2793 |
|
|
2023
Q4 | $106K | Hold |
35,400
| – | – | ﹤0.01% | 2712 |
|
|
2023
Q3 | $35K | Buy |
35,400
+19,800
| +127% | +$28.6K | ﹤0.01% | 2815 |
|
|
2023
Q2 | $22K | Sell |
15,600
-14,164
| -48% | -$19.8K | ﹤0.01% | 2863 |
|
|
2023
Q1 | $48K | Buy |
29,764
+1,122
| +4% | +$5.79K | ﹤0.01% | 2796 |
|
|
2022
Q4 | $178K | Buy |
28,642
+1,415
| +5% | +$10.1K | ﹤0.01% | 2569 |
|
|
2022
Q3 | $183K | Buy |
27,227
+9,408
| +53% | +$64.6K | ﹤0.01% | 2577 |
|
|
2022
Q2 | $113K | Buy |
17,819
+728
| +4% | +$4.13K | ﹤0.01% | 2732 |
|
|
2022
Q1 | $79K | Buy |
+17,091
| New | +$73.3K | ﹤0.01% | 2878 |
|
|
2021
Q4 | – | Sell |
-22,522
| Closed | -$271K | – | 3001 |
|
|
2021
Q3 | $271K | Buy |
22,522
+5,000
| +29% | +$72.8K | ﹤0.01% | 2615 |
|
|
2021
Q2 | $371K | Buy |
17,522
+480
| +3% | +$11.6K | ﹤0.01% | 2513 |
|
|
2021
Q1 | $478K | Buy |
17,042
+6,976
| +69% | +$206K | ﹤0.01% | 2390 |
|
|
2020
Q4 | $262K | Sell |
10,066
-3,100
| -24% | -$92.9K | ﹤0.01% | 2472 |
|
|
2020
Q3 | $489K | Sell |
13,166
-172,161
| -93% | -$6.82M | ﹤0.01% | 2100 |
|
|
2020
Q2 | $9.51M | Sell |
185,327
-15,515
| -8% | -$649K | ﹤0.01% | 1305 |
|
|
2020
Q1 | $6.33M | Buy |
200,842
+157,446
| +363% | +$8.31M | ﹤0.01% | 1298 |
|
|
2019
Q4 | $2.59M | Sell |
43,396
-297,631
| -87% | -$13.4M | ﹤0.01% | 1539 |
|
|
2019
Q3 | $12.5M | Buy |
341,027
+5,115
| +2% | +$203K | ﹤0.01% | 1254 |
|
|
2019
Q2 | $15.6M | Sell |
335,912
-129,645
| -28% | -$6.09M | ﹤0.01% | 1240 |
|
|
2019
Q1 | $18.7M | Buy |
465,557
+168,884
| +57% | +$7.58M | ﹤0.01% | 1193 |
|
|
2018
Q4 | $13.6M | Sell |
296,673
-6,363
| -2% | -$307K | ﹤0.01% | 1252 |
|
|
2018
Q3 | $13.4M | Buy |
303,036
+133
| +0% | +$6.11K | ﹤0.01% | 1322 |
|
|
2018
Q2 | $11.9M | Buy |
302,903
+8,059
| +3% | +$407K | ﹤0.01% | 1318 |
|
|
2018
Q1 | $21.3M | Buy |
294,844
+104,757
| +55% | +$7.69M | ﹤0.01% | 1160 |
|
|
2017
Q4 | $12.5M | Buy |
190,087
+111,723
| +143% | +$6.02M | ﹤0.01% | 1299 |
|
|
2017
Q3 | $3.93M | Sell |
78,364
-3,183
| -4% | -$153K | ﹤0.01% | 1466 |
|
|
2017
Q2 | $3.77M | Sell |
81,547
-12,570
| -13% | -$462K | ﹤0.01% | 1448 |
|
|
2017
Q1 | $3.32M | Sell |
94,117
-3,500
| -4% | -$80.1K | ﹤0.01% | 1478 |
|
|
2016
Q4 | $1.22M | Sell |
97,617
-2,443
| -2% | -$29.1K | ﹤0.01% | 1708 |
|
|
2016
Q3 | $1.39M | Buy |
100,060
+4,020
| +4% | +$45.6K | ﹤0.01% | 1635 |
|
|
2016
Q2 | $949K | Sell |
96,040
-545
| -0.6% | -$9.03K | ﹤0.01% | 1723 |
|
|
2016
Q1 | $1.63M | Hold |
96,585
| – | – | ﹤0.01% | 1572 |
|
|
2015
Q4 | $2.15M | Buy |
96,585
+7,313
| +8% | +$184K | ﹤0.01% | 1524 |
|
|
2015
Q3 | $2.11M | Hold |
89,272
| – | – | ﹤0.01% | 1540 |
|
|
2015
Q2 | $7.3M | Sell |
89,272
-35,372
| -28% | -$3.46M | ﹤0.01% | 1415 |
|
|
2015
Q1 | $11.5M | Buy |
+124,644
| New | +$8.04M | ﹤0.01% | 1301 |
|
Other funds holding ESPR
WA
TSC
O
VCM
